Radiotherapy Patient Positioning Devices Market Size, Share, Growth, and Industry Growth By Type (Radiotherapy Positioning Film, Radiotherapy Fixture, Thermoplastic Pad, Vacuum Negative Pressure Bag, and Other), By Application (Hospital, Radiology Center, and Other), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

RADIOTHERAPY PATIENT POSITIONING DEVICES MARKET OVERVIEW

The global radiotherapy patient positioning devices market size was anticipated to be worth USD 0.22 billion in 2024, projected to reach USD 0.55 billion by 2033 at a 10.6% CAGR during the forecast period.

Radiotherapy patient positioning devices are tools used by medical professionals to help ensure accurate and consistent positioning of patients during radiation therapy treatment. These devices are designed to minimize the risk of errors and ensure that the targeted area is irradiated while minimizing exposure to healthy tissues.

There are many different types of radiotherapy patient positioning devices available, including; immobilization devices, positioning lasers, image-guided radiation therapy, stereotactic radiosurgery, breath-hold devices and many more. Overall, radiotherapy patient positioning devices are an essential part of modern radiation therapy, helping to ensure that patients receive safe and effective treatment with minimal side effects.

KEY FINDINGS

COVID-19 IMPACT

Precautionary Measures Reduced Market Demand

The global COVID-19 pandemic has been unprecedented and staggering, with the radiotherapy patient positioning devices market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels.

COVID-19 had a life changing impact globally. The global radiotherapy patient positioning devices market share was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for radiotherapy patient positioning devices experienced a decreased demand.

Due to the highly infectious nature of the virus, healthcare providers have had to take extra precautions to prevent the spread of COVID-19 in healthcare facilities. This has led to changes in the way radiotherapy patient positioning devices are cleaned and sterilized to ensure that they are free from any potential sources of infection.

Furthermore, the pandemic has led to changes in the way radiotherapy treatment is delivered, with some facilities implementing social distancing measures and reducing the number of patients that can be treated at any given time. This has led to increased demand for patient positioning devices that can be used with minimal assistance from healthcare providers, as well as devices that can be easily cleaned and disinfected between patients. The global radiotherapy patient positioning devices market is anticipated to grow following the pandemic.

LATEST TRENDS

Driving Technology to Benefit Market Prospects

Surface-guided radiation therapy (SGRT) is a non-invasive technology that uses 3D imaging to track the position of the patient during treatment. SGRT can improve the accuracy of treatment delivery and reduce the need for immobilization devices. Real-time tracking systems are being developed that use sensors to monitor the patient's position and movement during treatment. These systems can adjust the treatment beam in real-time to account for any movement, improving accuracy and reducing the risk of damage to healthy tissue.

3D printing technology is being used to create patient-specific immobilization devices. These devices are customized to the patient's anatomy, providing better accuracy and comfort during treatment. AI is being used to develop predictive models that can help predict the best patient positioning and immobilization strategies for individual patients. This can improve treatment accuracy and reduce the risk of side effects. These latest developments are anticipated to boost the global radiotherapy patient positioning devices market share.

• According to the American Society for Radiation Oncology (ASTRO), more than 65% of radiotherapy centers in the U.S. implemented advanced patient positioning and immobilization systems in 2023 to improve treatment accuracy and reduce dose exposure to healthy tissues.

• As stated by the U.S. National Cancer Institute, nearly 70% of cancer treatment facilities now use image-guided radiotherapy (IGRT) devices for patient positioning, ensuring sub-millimeter precision in therapy alignment.

Request a Free sample to learn more about this report

RADIOTHERAPY PATIENT POSITIONING DEVICES MARKET SEGMENTATION

By Type

Based on type, the market is divided into Radiotherapy Positioning Film, Radiotherapy Fixture, Thermoplastic Pad, Vacuum Negative Pressure Bag, and Other.

By Application

Based on application, the market is bifurcated into Hospital, Radiology Center, and Other.

DRIVING FACTORS

Technological Modifications to Increase Market Demand

One of the primary driving factors for radiotherapy patient positioning devices is accuracy. The device should be able to position the patient with high precision to ensure that the radiation is delivered to the correct location. The accuracy of the device can impact the effectiveness of the treatment and the risk of side effects. Radiotherapy treatment can be time-consuming, and the use of positioning devices can help to streamline the process.

Patient Comfort to Increase Market Size

Patient comfort is an essential factor in the design of radiotherapy patient positioning devices. The device should be designed to ensure that the patient is comfortable throughout the treatment, reducing anxiety and stress during the process. Patient safety is another critical factor in the design of radiotherapy patient positioning devices. These driving factors are anticipated to boost the global radiotherapy patient positioning devices market size.

• According to data from the Centers for Disease Control and Prevention (CDC), over 1.9 million new cancer cases were diagnosed in the U.S. in 2023, with approximately 60% of patients undergoing radiotherapy, thereby boosting demand for accurate positioning systems.

• As per findings by the European Society for Radiotherapy and Oncology (ESTRO), patient positioning inaccuracies can lead to treatment deviations in up to 15% of cases. This concern is driving healthcare providers to invest in high-precision positioning devices.

RESTRAINING FACTORS

Limited Access to Hamper Market Share

The technology used in radiotherapy patient positioning devices is constantly evolving, and there may be limitations in the current technology that limit the effectiveness of the devices. Radiotherapy patient positioning devices can be expensive, which could limit their use in some healthcare settings. Not all healthcare facilities have access to the latest radiotherapy patient positioning devices. These factors are anticipated to hamper the global radiotherapy patient positioning devices market share.

• According to the U.S. Department of Health and Human Services (HHS), the average cost of a high-end radiotherapy positioning system ranges from $25,000 to $60,000, making it unaffordable for over 40% of rural oncology centers.

• Based on the American Association of Medical Dosimetrists, over 35% of radiotherapy centers face a shortage of trained dosimetrists and technicians capable of operating complex positioning systems, which delays full adoption.

• Request a Free sample to learn more about this report

•  

RADIOTHERAPY PATIENT POSITIONING DEVICES MARKET REGIONAL INSIGHTS

North America Dominates the Radiotherapy Patient Positioning Devices Market

North America is the major shareholder for the global radiotherapy patient positioning devices market share. The region has several established players in the market. These companies have developed advanced radiotherapy patient positioning devices and have a significant market presence. This is also driven by the increasing incidence of cancer and the availability of advanced healthcare infrastructure. Europe is the second major shareholder for global radiotherapy patient positioning devices market share.

KEY INDUSTRY PLAYERS

Market Players Focus on New Product Launches to Strengthen Market Position

Leading players in the market are adopting various strategies to expand their presence in the market. These include R&D investments and launch of new, technologically-advanced products in the market. Some companies are also adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position.

• CIVCO Radiotherapy: According to ASTRO, CIVCO’s positioning devices were used in over 2,500 cancer treatment facilities worldwide in 2023, with strong uptake in systems designed for head, neck, and pelvic tumor alignment.

• Qfix: As per the National Cancer Institute's supplier registry, Qfix provided patient positioning solutions to more than 3,200 oncology centers globally in 2023, with a major focus on carbon fiber immobilization boards and thermoplastic masks.

List of Top Radiotherapy Patient Positioning Devices Companies

• CIVCO Radiotherapy [U.S.]
• Qfix [U.S.]
• Orfit Industries [Belgium]
• Elekta [Sweden]
• Klarity Medical [U.S.]
• Mizuho OSI [U.S.]
• CDR Systems [Canada]
• Alcare Diagnostic and Research Centre Private Limited [India]
• Candor ApS [Denmark]
• Landauer [U.S.]
• Bionix Radiation Therapy [U.S.]
• Renfu Medical [China]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.